Watch PROK. Know when insiders buy.
One email the day a filing lands. Free.
Work order
34
FLAG · insiders 26, shorts 41
Insiders, 90 days
−$1.1M
net selling · 0 buys, 6 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP —P/E —DIV YIELD —FCF YIELD —REV TTM —NET INCOME −$84.2MNET CASH —52W 1.33 – 3.30NEXT EARNINGS Nov 9 EST.SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | — | — | — | −$48.4M | −$28.4M | — | — | −$40.4M | $3.8M | −$44.2M | Aug 10 |
| Q1 2026 · Mar 31 | — | — | — | −$44.9M | −$20M | — | — | −$41.7M | $3.8M | −$45.5M | May 15 |
| Q4 2025 · Dec 31derived | — | — | — | −$45.4M | −$19.2M | — | — | −$32.5M | $5.8M | −$38.3M | Mar 18 |
| Q3 2025 · Sep 30 | — | — | — | −$38.5M | −$16.5M | — | — | −$26.6M | $5.2M | −$31.8M | Nov 10 |
| Q2 2025 · Jun 30 | — | — | — | −$39.7M | −$16.6M | — | — | −$31.4M | $3.1M | −$34.5M | Aug 10 |
| Q1 2025 · Mar 31 | — | — | — | −$41.4M | −$16.7M | — | — | −$29.6M | $1.1M | −$30.7M | May 15 |
| Q4 2024 · Dec 31derived | — | — | — | −$51.6M | −$21.3M | — | — | −$24.2M | $25.5M | −$49.7M | Mar 18 |
| Q3 2024 · Sep 30 | — | — | — | −$49M | −$17.9M | — | — | −$29.2M | $2.4M | −$31.6M | Nov 10 |
| Q2 2024 · Jun 30 | — | — | — | −$43.1M | −$12.5M | — | — | −$38.3M | $636K | −$38.9M | Aug 12 |
| Q1 2024 · Mar 31 | — | — | — | −$40.1M | −$9.5M | — | — | −$34.6M | $960K | −$35.6M | May 12 |
| Q4 2023 · Dec 31derived | — | — | — | −$24.2M | −$5.7M | — | — | −$25.4M | $1.6M | −$27M | Mar 18 |
| Q3 2023 · Sep 30 | — | — | — | −$46.6M | −$11M | — | — | −$23.8M | $27.9M | −$51.7M | Nov 12 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | — | — | −$165M | −$69M | — | — | −$120.1M | $15.2M | −$135.3M | $0 | — |
| FY2024 · to Dec 31 | — | — | −$183.7M | −$61.2M | — | — | −$126.4M | $29.5M | −$155.9M | $0 | — |
| FY2023 · to Dec 31 | — | — | −$151.5M | −$35.5M | — | — | −$90.1M | $34.2M | −$124.3M | $9.5M | — |
| FY2022 · to Dec 31 | — | — | −$153M | −$148.1M | — | -0.23 | −$77.1M | $1.8M | −$78.9M | $0 | — |
| FY2021 · to Dec 31 | — | — | −$55.1M | −$55.1M | — | — | −$50.3M | $5.2M | −$55.5M | $0 | — |
| FY2020 · to Dec 31 | — | — | −$27M | −$26.7M | — | — | −$25.2M | $5.5M | −$30.6M | — | — |
Every number comes from PROKIDNEY CORP.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.